We are live on ! Find out more
SZYM

SOLAZYME INC COM STK (DE)
SZYM

Delisted

SZYM was delisted on the 10th of May, 2016.

122 hedge funds and large institutions have $456M invested in SOLAZYME INC COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 22 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

141% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 22

57% more capital invested

Capital invested by funds: $290M → $456M (+$166M)

16% more funds holding

Funds holding: 105122 (+17)

42% less call options, than puts

Call options by funds: $4.74M | Put options by funds: $8.21M

Holders
122
Holders Change
+17
Holders Change %
+16.19%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
29
Increased
53
Reduced
22
Closed
10
Calls
$4.74M
Puts
$8.21M
Net Calls
-$3.47M
Net Calls Change
-$1.96M
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$95M +$18.3M +1,559,076 +24%
PC
2
Passport Capital
California
$64.1M +$62.7M +5,325,277 +2,663%
Vanguard Group
3
Vanguard Group
Pennsylvania
$35.4M +$8.16M +693,449 +29%
State Street
4
State Street
Massachusetts
$18.7M -$1.13M -95,678 -6%
BIT
5
BlackRock Institutional Trust
California
$17.2M -$358K -30,395 -2%
Artisan Partners
6
Artisan Partners
Wisconsin
$16.7M +$11.5M +977,405 +212%
BFA
7
BlackRock Fund Advisors
California
$14.5M +$312K +26,475 +2%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$13.3M +$2.35M +199,899 +21%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$13.2M -$116K -9,900 -0.9%
WF
10
Welch & Forbes
Massachusetts
$10.3M +$2.13M +181,311 +26%
SCA
11
SAC Capital Advisors
Connecticut
$9.29M +$8.52M +723,700 +941%
Morgan Stanley
12
Morgan Stanley
New York
$7.58M +$1.36M +115,756 +22%
Invesco
13
Invesco
Georgia
$7.09M +$1.34M +113,931 +23%
Northern Trust
14
Northern Trust
Illinois
$7.01M -$772K -65,571 -10%
UBS AM
15
UBS AM
Illinois
$6.75M -$950K -80,713 -12%
BA
16
BlackRock Advisors
Delaware
$6.42M +$5.31M +451,052 +442%
AGA
17
Altrinsic Global Advisors
Connecticut
$6.23M +$1.73M +146,900 +38%
IHL
18
Investment House LLC
California
$5.74M +$30.1K +2,560 +0.5%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$5.31M +$2.72M +231,394 +102%
DP
20
DSAM Partners
United Kingdom
$5.24M +$5.31M +450,874 New
PRCM
21
Pine River Capital Management
Minnesota
$4.93M +$5M +425,000 New
Lazard Asset Management
22
Lazard Asset Management
New York
$4.53M -$5.56M -472,582 -55%
EAM
23
Eventide Asset Management
Massachusetts
$4.23M +$1.44M +122,800 +51%
CS
24
Credit Suisse
Switzerland
$4.19M +$2.21M +187,508 +108%
RA
25
Royce & Associates
New York
$4.07M +$1.72M +146,000 +71%

SZYM Hedge Fund Activity: Q1 2014 in Review

122 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in SOLAZYME INC COM STK (DE) (SZYM) for Q1 2014, worth a combined $456M — up 57% from $290M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SZYM positions and 10 closed out — a net gain of 19 holders — while 53 added to existing stakes and 22 trimmed.

The largest buyer was Passport Capital, adding an estimated $62.7M. The largest seller was Lazard Asset Management, cutting an estimated $5.56M.

  • 122 institutional investors held SOLAZYME INC COM STK (DE) (SZYM) as of Q1 2014, up from 105 in Q4 2013.
  • Funds reported $456M of SOLAZYME INC COM STK (DE) stock for Q1 2014, up 57% quarter-over-quarter.
  • 29 funds opened new SOLAZYME INC COM STK (DE) positions in Q1 2014 and 10 closed out, a net change of +19 holders.
  • The largest SOLAZYME INC COM STK (DE) buyer in Q1 2014 was Passport Capital, an estimated $62.7M added.
  • The largest SOLAZYME INC COM STK (DE) seller in Q1 2014 was Lazard Asset Management, an estimated $5.56M sold.

Based on aggregated 13F filings for Q1 2014.